These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17966590)

  • 21. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen.
    Percival A; Thorkildson P; Kozel TR
    Clin Vaccine Immunol; 2011 Aug; 18(8):1292-6. PubMed ID: 21697342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development.
    May RJ; Beenhouwer DO; Scharff MD
    J Immunol; 2003 Nov; 171(9):4905-12. PubMed ID: 14568972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.
    Eckert TF; Kozel TR
    Infect Immun; 1987 Aug; 55(8):1895-9. PubMed ID: 2440810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
    Todaro-Luck F; Reiss E; Cherniak R; Kaufman L
    Infect Immun; 1989 Dec; 57(12):3882-7. PubMed ID: 2680986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
    Mukherjee S; Lee S; Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1994 Mar; 62(3):1079-88. PubMed ID: 8112842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The evaluation of the specific type of capsular polysaccharide of Cryptococcus neoformans as an immunogen and positive-control antigen].
    Toraño Peraza GT; Rodríguez Acebo W; Martínez Machín G
    Rev Cubana Med Trop; 1998; 50(3):207-8. PubMed ID: 10349445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.
    Mukherjee J; Zuckier LS; Scharff MD; Casadevall A
    Antimicrob Agents Chemother; 1994 Mar; 38(3):580-7. PubMed ID: 8203858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.
    Probert M; Zhou X; Goodall M; Johnston SA; Bielska E; Ballou ER; May RC
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody.
    Zhang H; Zhong Z; Pirofski LA
    Infect Immun; 1997 Apr; 65(4):1158-64. PubMed ID: 9119446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans.
    Feldmesser M; Kress Y; Casadevall A
    J Infect Dis; 1998 Jun; 177(6):1639-46. PubMed ID: 9607844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.
    Valadon P; Nussbaum G; Boyd LF; Margulies DH; Scharff MD
    J Mol Biol; 1996 Aug; 261(1):11-22. PubMed ID: 8760499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and partial characterization of monoclonal antibodies to Pasteurella haemolytica A1 capsular polysaccharide and lipopolysaccharide.
    Penaredondo MV; Maheswaran SK; Whiteley LO; Ames TR; Leininger JR
    Am J Vet Res; 1988 Nov; 49(11):1962-8. PubMed ID: 2470277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
    Zaragoza O; Casadevall A
    Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals.
    Deshaw M; Pirofski LA
    Clin Exp Immunol; 1995 Mar; 99(3):425-32. PubMed ID: 7882565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.
    Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML
    Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformans.
    Todaro-Luck F; White EH; Reiss E; Cherniak R
    Mol Cell Probes; 1989 Dec; 3(4):345-61. PubMed ID: 2482437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release.
    Cleare W; Casadevall A
    Med Mycol; 1999 Aug; 37(4):235-43. PubMed ID: 10421858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
    Netski D; Kozel TR
    Infect Immun; 2002 Jun; 70(6):2812-9. PubMed ID: 12010967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced binding of capsular polysaccharides of Cryptococcus neoformans to polystyrene microtitration plates for enzyme-linked immunosorbent assay.
    Cherniak R; Cheeseman MM; Reyes GH; Reiss E; Todaro F
    Diagn Clin Immunol; 1988; 5(6):344-8. PubMed ID: 3064947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods of Cryptococcal Polysaccharide Analysis Using ELISA.
    Wear MP; McConnell SA; Greengo SD; Lopes LL; Casadevall A
    Methods Mol Biol; 2024; 2775():239-255. PubMed ID: 38758322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.